false 0000021076 0000021076 2025-01-23 2025-01-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
__________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): January 23, 2025

THE CLOROX COMPANY
(Exact name of registrant as specified in its charter)
__________________

Delaware 1-07151 31-0595760
(State or other jurisdiction of (Commission File Number) (I.R.S. Employer
incorporation)   Identification No.)

1221 Broadway, Oakland, California 94612-1888
(Address of principal executive offices) (Zip code)

(510) 271-7000
(Registrant's telephone number, including area code)

Not applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading
Symbol(s)
Name of each exchange on which registered
Common Stock - $1.00 par value CLX New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company     

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ☐

 

 

 

Item 5.02  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On January 23, 2025, Kevin Jacobsen, Executive Vice President – Chief Financial Officer of The Clorox Company (the “Company”), provided notice of his intention to retire from the Company effective April 1, 2025, following nearly 30 years of service. Mr. Jacobsen will continue in an advisory capacity at the Company until June 2025.

(c) On January 23, 2025, the Management Development and Compensation Committee (the “MDCC”) of the Board of Directors of the Company appointed Luc Bellet, age 46, to be Executive Vice President – Chief Financial Officer, effective April 1, 2025.

Mr. Bellet is currently the Company’s Vice President – Treasurer, a position he has held since October 2023. Prior to this role, Mr. Bellet served as Vice President – Financial Planning & Analysis from April 2018 to October 2023. Mr. Bellet joined the Company in 2006 and has held a number of senior leadership roles in the Company’s financial organization over the years, including in internal audit, Global Product Supply and various business units.

In connection with Mr. Bellet’s appointment, on January 23, 2025, the MDCC approved an increase in Mr. Bellet’s base salary to $725,000 and an increase in his short-term incentive target from 50% to 100% of his salary, effective as of April 1, 2025. In addition, on April 1, 2025, Mr. Bellet will receive a grant of restricted stock units that have an aggregate fair value of $400,000, which will vest over four years, and performance shares with an aggregate target fair value of $600,000 and a three-year performance period ending June 30, 2027.

Mr. Bellet has no familial relationships nor related party transactions with the Company that would require disclosure under Items 401(d) or 404(a) of Regulation S-K (17 CFR 229.401(d) and 229.404(a)) in connection with his appointment described above.

Item 7.01 Regulation FD Disclosure

A copy of the press release announcing the future Chief Financial Officer changes is filed as Exhibit 99.1 hereto and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

See the Exhibit Index below.

EXHIBIT INDEX

Exhibit   Description
99.1   Press Release dated January 28, 2025 of The Clorox Company
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

2 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    THE CLOROX COMPANY
 
Date:   January 28, 2025 By:   /s/ Angela Hilt
      Angela Hilt
      Executive Vice President – Chief Legal Officer
       

3 

Exhibit 99.1

PRESS RELEASE  
     

Clorox CFO Kevin Jacobsen to Retire; Luc Bellet Named CFO

OAKLAND, California, Jan. 28, 2025 — The Clorox Company (NYSE: CLX) today announced that after nearly 30 years with the company, Chief Financial Officer Kevin Jacobsen has decided to retire effective April 1. Luc Bellet, an 18-year Clorox veteran, will succeed Kevin and they will work together on an orderly transition.

Jacobsen joined Clorox in 1995 and has served as CFO since 2018. During his tenure as CFO, Jacobsen has driven the company’s IGNITE strategy and played a significant role in evolving the company’s portfolio while delivering strong financial results and total shareholder returns, which were in part enabled by his guidance on the company’s strong margin transformation efforts.

“Kevin has been a change agent in driving our overall transformation and execution of our IGNITE strategy. I want to extend my heartfelt gratitude to Kevin for his partnership, leadership and numerous contributions to Clorox, and I wish him the very best in his retirement,” said Linda Rendle, Chair and CEO. “We are fortunate to have a strong leader in Luc Bellet ready to step into this important role, which is a testament to Kevin’s continued development of his team and our thoughtful succession planning. I’m confident that Luc will build on the solid foundation Kevin has created as we drive profitable growth for the future and enhance long-term shareholder value.”

Effective April 1, Bellet will be appointed executive vice president and chief financial officer, reporting to CEO Linda Rendle, and will serve on the company’s executive committee. Bellet is currently Clorox’s treasurer and has worked in leadership roles in all facets of the company’s financial organization – including financial planning and analysis, internal audit and business development.

“Our business is in a position of operational strength and we’re embarking on an important phase of growth through our digital transformation,” said Jacobsen. “Luc is the right leader to drive our business forward at this time, and I’m confident that his vast experience across all aspects of our business will enable continued growth and success.”

Kevin will actively serve in his CFO role through the transition on April 1 and then continue at Clorox in an advisory capacity until his retirement in June.

About The Clorox Company
The Clorox Company (NYSE: CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® as well as international brands such as Clorinda®, Chux® and Poett®. Headquartered in Oakland, California, since 1913, Clorox was one of the first in the U.S. to integrate ESG into its business reporting. In 2024 the company was ranked No. 1 on Barron's 100 Most Sustainable Companies list for the second consecutive year. Visit thecloroxcompany.com to learn more.

Media Relations

corporate.communications@clorox.com

Investor Relations

investorrelations@clorox.com

CLX-F

 

v3.24.4
Cover
Jan. 23, 2025
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 23, 2025
Entity File Number 1-07151
Entity Registrant Name THE CLOROX COMPANY
Entity Central Index Key 0000021076
Entity Tax Identification Number 31-0595760
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1221 Broadway
Entity Address, City or Town Oakland
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94612-1888
City Area Code 510
Local Phone Number 271-7000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock - $1.00 par value
Trading Symbol CLX
Security Exchange Name NYSE
Entity Emerging Growth Company false

Clorox (NYSE:CLX)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Clorox Charts.
Clorox (NYSE:CLX)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Clorox Charts.